Claims for Patent: 5,183,757

Summary for Patent: 5,183,757

Title:	Process for the production, desiccation and germination of conifer somatic embryos
Abstract:	A process to assist in germination of spruce somatic embryos. The embryos are desiccated at humidity, preferably in the range of 85 to 99%. A process that differentiates somatic embryos of conifer comprises contacting embryogenic calli with a medium containing abscisic acid. A process for determining the quality of a plant to embryo is also described. That process comprises identifying the storage protein content of the embryo and comparing that content with the storage protein content of mature embryos of the same species.
Inventor(s):	Roberts; Dane R. (Vancouver, CA)
Assignee:	British Columbia Research Corporation (Vancouver, CA)
Application Number:	07/388,598
Patent Claims:	1. A process for propagation of spruce somatic embryos which includes the steps of differentiating spruce somatic embryos in contact with a growth medium containing abscisic acid, separating the somatic embryos from said medium, and germinating the somatic embryos, characterized in that the embryos are matured on said medium and are partially dried prior to germination by exposing mature embryos separated from the said medium to an atmosphere having from greater than 85% up to 99% humidity. 2. The process of claim 1 wherein the humidity of the atmosphere is established in a closed area by the presence of liquid selected from the group consisting of: water; and an aqueous solution of a salt providing a humidity of from 90% to less than 99%, wherein the embryos are not in direct contact with said liquid while in the closed area. 3. The process of claim 2 wherein the liquid is an aqueous solution of a salt selected from the group consisting of: saturated sodium dihydrogen phosphate providing a humidity of about 95%; and saturated zinc sulphate providing a humidity of about 90%. 4. The process of claim 2 wherein the liquid is sterile water. 5. The process of claim 1 wherein the mature somatic embryos are derived from embryogenic calli initiated from immature embryos and wherein said somatic embryos are differentiated in contact with a growth medium containing 30-40 .mu.M abscisic acid and 0.1-10 .mu.M indole-3-butyric acid.

Details for Patent 5,183,757

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23